Drugs / Gen1E-1124
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04728061 | Jan → Jun 2021 | — | GEn1E Lifesciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gen1E-1124 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04728061 ↗ |
| Route | Intravenous | “Intravenously-infused Gen1E-1124 in vehicle.” NCT04728061 ↗ |